Natural killer cells (CD56, CD16) as a factor of local antitumor immunity in breast cancer

Voprosy Onkologii

Volumn 51, Issue 4, 2005, Pages 447-449

  Ellinidi, V N ^a   Anikeeva, N V ^a   Goncharova, O A ^b   Krasnozhon, D A ^b  

^a Emergences and Elimination of Consequences of Natural Disasters   (Russian Federation)

^b Oncological Dispensary of Leningrad Region ^*  (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; FC RECEPTOR; TUMOR MARKER;

ARTICLE; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; LYMPH NODE METASTASIS; NATURAL KILLER CELL; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS;

ANTIGENS, CD56; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KILLER CELLS, NATURAL; LYMPHATIC METASTASIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, IGG; TUMOR MARKERS, BIOLOGICAL;

EID: 29844448868     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ben-Hur H., Cohen O., Schneider D., Gurevich P. The role of lymphocytes and macrophages in human breast tumorogenesis: an immunohistochemical and morphometric study // Anticancer Res. - 2002. - Vol. 22. - P. 1231-1238.
2. Carson W.E., Parihar R., Lindemann et al. Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her-2/neu-positive breast cancer cells // Europ. J. Immunol. - 2001. - Vol. 31. - P. 3016-3025.
3. Comes A., Di Carlo E., Musiani P. et al. INF-gamma-independent synergetic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice // Europ. J. Immunol. - Ibid. - 2002. - Vol. 32. - P. 1914-1923.
4. Cooper M.A., Fehniger T.A., Turner S.C. et al. Human natural killer cells a unique innate immunoregulatory role for the CD56 bright subset // Blood. - 2001. - Vol. 97. - P. 3146-3151.
5. Dettke M., Loibner H. Different types of FC gamma-receptors are involved in anti-lewis Y antibody induced effector functions in vitro // Brit. J. Cancer. - 2000. - Vol. 82. - P. 441-445.
6. Garzetti G.G., Civiattini A., Goteri G. et al. Natural killer cell activity in stage I endometrial carcinoma: correlation with nuclear grading, myometrial invasion, and immunoreactivity of proliferating cell nuclear antigen // Gynecol. Oncol. - 1994. - Vol. 55. - P. 111-114.
7. Gercell-Taylor C., Hoffman J.P., Taylor D.D. et al. Interleukin-2 activation of cytotoxic cells in postmastectomy seroma // J. Surg. Res. - 1996. - Vol. 61. - P. 89-96.
8. Lorenzen J., Lewis C.E., McCracken D. etal. Human tumor-associated NK-cell secrete increased amounts of interferon-gamma and interleukin-4 // Brit. J. Cancer. - 1991. - Vol. 64. - P. 457-462.
9. Meehan K.R., Wu A., Hassan R. et al. Ex vivo cytokine activation of peripheral blood stem cells: a potential role for adoptive cellular immunoterapy // J. Hematother. Stem. Cell. Res. - 2001. - Vol. 10. - P. 283-290.
10. Pai M.R., Pai K.N., Rao R.V. et al. Connective tissue stromal changes in tumours and tumor-like lesions of the breast // Indian J. Path. Microbiol. - 1999. - Vol. 42. - P. 266-273.
11. Ran M., Teillaud J.L., Fridman W.H. et al. Increased expression of Fc gamma receptor in cancer patients and tumor bearing mice // Mol. Immunol. - 1988. - Vol. 25. - P. 1159-1167.
12. Son Y.I., Dallal R.M., Mailliard R.B. et al. Interleukin-18 (IL-18) synergism with IL-2 to enhance cytotoxicity, interferon-γ production, and expansion of natural killer cells // Cancer Res. - 2001. - Vol. 61. - P. 884-888.
13. Wahlberg B.J., Burholt D.R., Kornblith P. et al. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay // J. Immunol. Methods. - 2001. - Vol. 253. - P. 69-81.